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Abstract
We have previously identified pyloric pressures and plasma cholecystokinin
(CCK) concentrations as independent determinants of energy intake following
administration of intraduodenal lipid and intravenous CCK. We evaluated in
healthy men whether these parameters also determine energy intake in
response to intraduodenal protein, and whether, across the nutrients, any pre-
dominant gastrointestinal (GI) factors exist, or many factors make small con-
tributions. Data from nine published studies, in which antropyloroduodenal
pressures, GI hormones, and GI /appetite perceptions were measured during
intraduodenal lipid or protein infusions, were pooled. In all studies energy
intake was quantified immediately after the infusions. Specific variables for
inclusion in a mixed-effects multivariable model for determination of inde-
pendent predictors of energy intake were chosen following assessment for
collinearity, and within-subject correlations between energy intake and these
variables were determined using bivariate analyses adjusted for repeated mea-
sures. In models based on all studies, or lipid studies, there were significant
effects for amplitude of antral pressure waves, premeal glucagon-like peptide-1
(GLP-1) and time-to-peak GLP-1 concentrations, GLP-1 AUC and bloating
scores (P < 0.05), and trends for basal pyloric pressure (BPP), amplitude of
duodenal pressure waves, peak CCK concentrations, and hunger and nausea
scores (0.05 < P ≤ 0.094), to be independent determinants of subsequent
energy intake. In the model including the protein studies, only BPP was iden-
tified as an independent determinant of energy intake (P < 0.05). No single
parameter was identified across all models, and effects of the variables identi-
fied were relatively small. Taken together, while GI mechanisms contribute to
the regulation of acute energy intake by lipid and protein, their contribution
to the latter is much less. Moreover, the effects are likely to reflect small,
cumulative contributions from a range of interrelated factors.
ª 2016 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
This is an open access article under the terms of the Creative Commons Attribution License,
which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
2016 | Vol. 4 | Iss. 17 | e12943
Page 1
Physiological Reports ISSN 2051-817X
Introduction
In healthy humans, energy intake and expenditure are, in
most cases, balanced precisely over long periods of time,
so that body weight is stable. This energy homeostasis is
controlled by complex interactions between central and
peripheral feedback signals, including neurohumoral
responses to ingested food (Woods et al. 2000; Cummings
and Overduin 2007). The arrival of nutrients in the small
intestine modulates a number of gastrointestinal (GI)
functions, including gastroduodenal motility (Heddle
et al. 1988a; Cook et al. 1997; Pilichiewicz et al. 2007b),
associated with a slowing of gastric emptying (Heddle
et al. 1989), and the stimulation of putative eating-inhibi-
tory gut hormones, including cholecystokinin (CCK) (Fel-
trin et al. 2007; Pilichiewicz et al. 2007b), glucagon-like
peptide-1 (GLP-1) (Feinle et al. 2002; Pilichiewicz et al.
2007a; Ryan et al. 2013), and peptide YY (PYY) (Feltrin
et al. 2007; Pilichiewicz et al. 2007b), as well as the sup-
pression of ghrelin (Parker et al. 2005; Feltrin et al. 2006;
Cukier et al. 2008), the only known orexigenic gut hor-
mone (Tschop et al. 2000; Cummings et al. 2001; Wren
et al. 2001). The stimulation of phasic and tonic pyloric
pressures is critical for the slowing of gastric emptying by
nutrients (Heddle et al. 1989). Among the macronutri-
ents, lipid appears to have the most potent effects to
modulate GI motor and hormone functions (Andrews
et al. 1998; Pilichiewicz et al. 2007a,b; Seimon et al.
2009a; Ryan et al. 2013). Our pooled data analysis of
eight studies from our laboratory, in which antropyloro-
duodenal pressures, GI hormones, and GI/appetite per-
ceptions were measured during intraduodenal lipid, or
intravenous CCK, infusions, indicated that the magnitude
of the stimulation of pyloric pressures and plasma CCK
concentrations is independent determinants of subsequent
energy intake in healthy men (Seimon et al. 2010), con-
sistent with the concept that both pyloric pressures and
CCK are important, in the acute regulation of energy
intake.
Protein is generally regarded as the most satiating
macronutrient (Latner and Schwartz 1999; Weigle et al.
2005; Batterham et al. 2006; Westerterp-Plantenga et al.
2009), although recent studies from our laboratory in lean
subjects have shown that orally ingested high-protein or
high-fat meals (Brennan et al. 2012), and intraduodenal
infusions of pure fat or protein (Ryan et al. 2013), have
comparable effects to reduce energy intake. However, in
these studies, despite equipotent effects on energy intake,
the effects of intraduodenal protein to stimulate pyloric
pressures and plasma CCK and GLP-1 concentrations
were much less than those of intraduodenal lipid, whereas
protein had more potent effects to stimulate plasma insu-
lin and glucagon (Ryan et al. 2013). These observations,
accordingly, suggest that the energy intake-suppressant
effects of protein may not be mediated by these GI mech-
anisms to the same extent as for lipid, which warrants
further evaluation. Over the last years, we have performed
a number of studies relating to the effects of protein and
amino acids on GI function and energy intake (Ryan
et al. 2012, 2013; Steinert et al. 2014, 2015). This analysis
was stimulated by the recognition that, in our previous
pooled analysis (Seimon et al. 2010), (1) effects of protein
were not evaluated; and (2) we included studies utilizing
intravenous hormone infusions, particularly exogenous
CCK, which is known to potently stimulate pyloric pres-
sures and increase plasma CCK concentrations to supra-
physiological levels, and, thus, may have led to an
overestimation of the role of these two outcomes. Because
of the potent energy intake-suppressant, but more modest
GI, effects of protein, we hypothesized, based on our
recent study (Ryan et al. 2013), that, in contrast to lipid,
GI mechanisms would not be identified as independent




A total of 117 healthy, normal-weight men, aged
26  3 years, and with a BMI of 22.6  0.8 kg/m2, were
included in this pooled data analysis (Feltrin et al. 2004,
2006, 2008; Little et al. 2005; Pilichiewicz et al. 2007b;
Seimon et al. 2009a; Ryan et al. 2012, 2013; Steinert et al.
2014, 2015) (Table 1). All participants were unrestrained
eaters with a score of ≤12 on the eating-restraint compo-
nent of the three-factor eating questionnaire (Stunkard
and Messick 1985). Subjects who smoked, consumed
>20 g of alcohol/day, had a history of GI symptoms, or
took medication known to affect appetite, eating, or GI
function were excluded. Each subject provided informed,
written consent before their inclusion, and the Royal Ade-
laide Research Ethics Committee approved the study pro-
tocols, and studies were performed in accordance with
the Declaration of Helsinki.
Study design
Data from nine published studies (Feltrin et al. 2004,
2006, 2008; Little et al. 2005; Pilichiewicz et al. 2007b;
Seimon et al. 2009a; Ryan et al. 2012, 2013; Steinert et al.
2014, 2015), performed in our laboratory between 2003–
13, were pooled for this analysis. All studies used identical
methods and techniques and evaluated the outcome mea-
sures of interest (Table 2). While, as in our previous
pooled analysis (Seimon et al. 2010), data were analyzed
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using the same statistical tests that would be appropriate
for an individual participant meta-analysis, it would be
inappropriate to refer to our analysis as such because the
studies included were not identified through a systematic
review (Simmonds et al. 2005).
Study protocols
Each study assessed the effects of ID infusions of nutri-
ents (e.g., triglyceride or fatty acids, protein or amino
acids) and appropriate control solutions on antropyloro-
duodenal pressures, GI hormone release, GI/appetite per-
ceptions, and energy intake. Information regarding the
study interventions in each study is provided in Table 1.
Detailed study protocols have been described in the origi-
nal publications (Feltrin et al. 2004, 2006, 2008; Little
et al. 2005; Pilichiewicz et al. 2007b; Seimon et al. 2009a;
Ryan et al. 2012, 2013; Steinert et al. 2014, 2015). Briefly,
in all studies, participants attended the laboratory in the
Discipline of Medicine, Royal Adelaide Hospital, at
0830 h after an overnight fast, for multiple study visits in
randomized order. On arrival, a small-diameter mano-
metric catheter (outer diameter: 3.5 mm; total length:
100 cm; Dentsleeve International Ltd, Mississauga, Ontar-
io, Canada) was inserted through an anesthetized nostril
into the stomach and allowed to pass into the duodenum
by peristalsis (Heddle et al. 1989). The catheter consisted
of 16 side holes, spaced at 1.5 cm intervals, to measure
pressures in the antrum (channels 1–6), pylorus (channels
7–9; 4.5-cm sleeve sensor), and duodenum (channels 10–
16), and an additional side hole located in the duodenum
for ID infusions. An intravenous cannula was placed into
a right forearm vein for regular blood sampling for subse-
quent measurements of plasma GI hormone, and/or insu-
lin, concentrations. Once the catheter was placed
correctly, as described (Heddle et al. 1988a), fasting
motility was observed until the occurrence of phase III of
the interdigestive migrating motor complex. Immediately
after the end of phase III activity, in phase I, a baseline
blood sample was taken, and the subject completed a
visual analog scale (VAS) questionnaire to assess GI per-
ceptions (Parker et al. 2004). ID infusion of nutrient or
control solutions commenced, and antropyloroduodenal
pressures were recorded throughout the infusion period.
Further blood samples were collected, and VAS question-
naires completed, at regular intervals. At the end of each
ID infusion, the catheter and cannula were removed, and
the subject was presented with a standardized, cold, buf-
fet-style meal (Nair et al. 2009). The meal consisted of
white and whole-meal breads, sliced, cold meats (ham,
Table 1. Subject and protocol details for each study included in the data analysis.
Study no. Authors (References) Subject (n) Age (year) BMI (kg/m2) Study intervention
1 Feltrin et al. (2004, 2006)1 72 24  4 22.0  1.6 ID saline (control), 0.375 kcal/min decanoic
or dodecanoic acid for 90 min. Buffet
meal at 90 min.
2 Little et al. (2005) 13 23  2 23.6  0.5 ID saline, 0.1, 0.2, or 0.4 kcal/min dodecanoic
acid for 90 min. Buffet meal at 90 min.
3 Pilichiewicz et al. (2007b) 16 31  3 23.8  0.5 ID saline, 0.25, 1.5, or 4 kcal/min of 10%
Intralipid for 50 min. Buffet meal at 50 min.
4 Feltrin et al. (2008) 13 26  2 22.9  0.6 ID saline, 0.4 kcal/min of dodecanoic,
or oleic acid for 60 min. Buffet meal at 60 min.
5 Seimon et al. (2009b) 10 25  3 22.8  0.4 ID saline, 2.8 kcal/min of fat emulsions
with droplet sizes of 0.26, 30, or 170 lm
for 120 min. Buffet meal at 120 min.
6 Ryan et al. (2012) 16 27  3 22.1  0.6 ID saline, 0.5, 1.5, or 3 kcal/min of 18.1%
hydrolyzed whey protein for 60 min.
Buffet meal at 60 min.
7 Ryan et al. (2013) 20 27  3 22.4  0.4 ID saline, 3 kcal/min of 18.1% hydrolyzed
whey protein or 20% Intralipid for 90 min.
Buffet meal at 90 min.
8 Steinert et al. (2014) 10 27  9 22.5  2.1 ID saline, 0.075 or 0.15 kcal/min of L-tryptophan
for 90 min. Buffet meal at 90 min.
9 Steinert et al. (2015) 12 25  2 21.9  0.4 ID saline, 0.15 or 0.45 kcal/min of L-leucine
for 90 min. Buffet meal at 90 min.
ID, intraduodenal. Data are means  SEM.
1Parts of the hormone data were analyzed and published separately, which resulted in two publications.
2Plasma was available in only seven of the eight subjects included in the analyses.
ª 2016 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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chicken), cheese, lettuce, tomato, cucumber, mayonnaise,
butter, apple, banana, yoghurt, chocolate custard, fruit
salad, iced coffee, orange juice, and water. Subjects were
allowed to eat as much as they wished for up to 30 min,
until they felt comfortably full.
Measurements
APD pressures
APD pressures were digitized using a computer-based sys-
tem running commercially available software and analyzed
for (1) the number and amplitude of antral and duodenal
pressure waves; (2) basal pyloric pressure (BPP; “tone”);
and (3) the number and amplitude of isolated pyloric
pressure waves (IPPWs) (Heddle et al. 1988b). Antral and
duodenal pressure waves were expressed as total numbers
and mean amplitudes (mmHg). For IPPWs, number of
premeal IPPWs (i.e., during the 15-min period immedi-
ately before the buffet meal), the peak number, and the
time (min)-to-peak number during ID infusions, total
number, and areas under the curve (AUCs, calculated
using the trapezoidal rule) of total number (min) and
amplitude (mmHgmin) were quantified. BPP was
expressed as peak pressures (mmHg), time (min)-to-peak
pressure, and AUC (mmHgmin) over the infusion per-
iod.
Hormone concentrations
Venous blood samples were collected, processed, and
stored for later analysis of total ghrelin, CCK, total PYY,
total GLP-1, and insulin. Plasma total ghrelin (pmol/L)
was measured by radioimmunoassay, without peptide
extraction (Phoenix Pharmaceuticals, Mountain View,
CA). No cross-reactivities with any relevant molecule have
been reported. Intra- and interassay coefficients of varia-
tion (CVs) were 5.0% and 15.0%, respectively. The detec-
tion limit was 13 pmol/L. Plasma CCK-8 (pmol/L) was
measured by radioimmunoassay after ethanol extraction
using an adaptation of a previously published method
(Santangelo et al. 1998). Intra- and interassay CVs were
8.3% and 12.6%, respectively. The detection limit was
1 pmol/L. Plasma total GLP-1 (pmol/L) was measured by
radioimmunoassay (Millipore, Billerica, MA). The anti-
body used did not cross-react with glucagon, gastric inhi-
bitory polypeptide, or other gut or pancreatic peptides.
Intra- and interassay CVs were 4.8% and 6.8%, respec-
tively. The detection limit was 3 pmol/L. Plasma total
PYY (pmol/L) was measured by radioimmunoassay
(Linco Research, St. Charles, MO). Intra- and interassay
CVs were 5.3% and 7.0%, respectively. The detection
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measured by an ELISA assay (Mercodia, Uppsala, Swe-
den). Intra- and interassay CVs were 2.9% and 8.8%,
respectively. The detection limit was 1 mU/L.
For CCK, premeal and peak concentrations (pmol/L),
the time (min)-to-peak concentrations, and the AUC
(pmolmin/L) over the infusion period were calculated.
For ghrelin, PYY, GLP-1, and insulin, premeal concentra-
tions (pmol/L or mU/L, as appropriate) and AUC
(pmolmin/L or mUmin/L, as appropriate) were calcu-
lated. Peak concentrations were not calculated for ghrelin,
PYY, GLP-1, and insulin because concentrations were
shown to continue to rise, or decline (for ghrelin),
throughout the infusion period.
GI/appetite perceptions and energy intake
Hunger, desire to eat, prospective consumption, fullness,
nausea, and bloating were rated using validated 100-mm
VAS scales (Parker et al. 2004) and expressed as AUCs
over the infusion period (mmmin). Energy intake (kJ)
was determined from the food consumed (g) at the buffet
meal, by weighing the different food items before and
after consumption, and then calculating their energy con-
tent using commercially available software (Foodworks;
Xyris Software, Highgate Hill, QLD, Australia) (Feltrin
et al. 2004; Ryan et al. 2013).
Statistical analysis
Statistical analyses were performed using SPSS 22 software
(2013, IBM Corp, Armonk, NY).
Within-subject correlations, adjusted for repeated mea-
sures, were performed to assess the strength of bivariate
relations between energy intake and each hormone, motil-
ity, and GI/appetite perception variable (Bland and Alt-
man 1995). Variables were then entered simultaneously
into a multivariable maximum-likelihood linear mixed-
effects model, adjusted for repeated visits per subjects and
the clustering of subjects within studies, to determine the
independent effects of each variable on energy intake
(Raudenbush and Bryk 2002). This is equivalent to the
one-step analysis approach in a meta-analysis of individ-
ual participant data (Riley et al. 2010).
Analyses were conducted for all studies combined
(models 1a, 1b), for the lipid-based studies (models 2a,
2b), and for the protein-based studies (model 3). Because
GLP-1 and PYY were not measured in all studies, the
multivariable analyses were conducted as two separate
models for ‘all studies’ and for the ‘lipid studies’. Models
1a and 2a considered all variables measured across all
studies plus PYY. Models 1b and 2b considered all vari-
ables measured across all studies plus GLP-1. Variables
were included in the multivariable models after screening
for multicollinearity and excluding related parameters
from the same underlying motility, hormone, or GI/ap-
petite perception variable, as indicated by the variance
inflation factors and condition indices. Where related
variables were collinear, parameters were selected for
inclusion based on how they best reflected the observed
physiological response over the study periods. These selec-
tions were made without referring to the model results to
avoid post hoc variable selection. Further exclusion of
variables was conducted for the lipid and protein sub-
groups, to reduce the models to a number of parameters
appropriate for the reduced sample sizes. For this pur-
pose, F-statistics were used to exclude the variables that
least contributed to the model, analogous to backward
variable selection. Thus, the following variables were
excluded in the process: IPPW time-to-peak number,
IPPW number AUC, BPP time-to-peak pressure, CCK
premeal, and CKK time to peak. Based on the same prin-
ciples, further variables were excluded to reach a final
model with an appropriate number of parameters, includ-
ing, from the lipid subgroup, mean amplitude of antral
pressure waves, IPPW amplitude AUC, BPP AUC, mean
amplitude of duodenal pressure waves, AUCs for CCK,
PYY, GLP-1, prospective consumption and fullness, and
from the protein subgroup, additionally IPPW peak num-
ber, number of duodenal pressure waves, and desire to
eat AUC. At each step, the models were examined for
consistency and robustness of the parameter estimates.
Data are expressed as means  standard error of the
mean (SEM) or standard deviation (SD), as indicated,




Within-subject correlations between energy intake and
each of the measured variables are presented in Table 3.
Collinearity was present between a number of variables;
thus, related variables from the same underlying motility,
hormone, or GI/appetite perception variable were
excluded from the multivariate model to guarantee a
robust estimation of the regression effects.
Models 1a and 1b (all studies)
Within the variables characterizing IPPWs, peak number,
total number, and AUC of the number were strongly
associated with each other (all r ≥ 0.83). Of these vari-
ables, AUC of the number was excluded from all multi-
variate models because it least characterized the IPPW
response. Among the CCK variables, peak concentration
ª 2016 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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and AUC were strongly correlated (r = 0.87), and peak
concentration was included because it best described the
hormone profile.
Models 2a and 2b (lipid studies)
Of the variables characterizing IPPWs in these studies, peak
number, total number, and AUC of the number were
strongly associated with each other (all r ≥ 0.82); thus,
AUC of the number was excluded because it least character-
ized the IPPW response. For the BPP variables, peak pres-
sure and AUC were strongly correlated (r = 0.85); thus,
peak pressure was included because it showed a slightly
stronger correlation with energy intake. Among the CCK
variables, peak concentration and AUC were strongly cor-
related (r = 0.88), and peak concentration was included
because it best characterized the CCK response. Within the
GI/appetite perception variables, AUCs for hunger, desire
to eat, and prospective consumption were correlated mod-
erately with each other (all r ≤ 0.77); thus, AUC for
prospective consumption was excluded.
Model 3 (protein studies)
All variables characterizing IPPWs were very strongly cor-
related (r ≥ 0.89); thus, total number was included in the
multivariate model because it showed the highest F-statis-
tics. Of the BPP variables, peak pressure and AUC were
strongly correlated (r = 0.70), and peak pressure was
selected for inclusion because it showed a stronger corre-
lation with energy intake. Within the CCK variables, peak
concentration and AUC were strongly correlated
(r = 0.91); thus, peak concentration was included because
it best characterized the CCK response. AUCs for hunger,
desire to eat, and prospective consumption were modestly
associated with each other (all r ≤ 0.66); thus, hunger was
included based on the highest F-statistics. GLP-1 and
PYY premeal concentrations were strongly correlated with
the corresponding AUCs (r ≥ 0.88); premeal concentra-
tions were included because they showed stronger correla-
tions with energy intake.
None of the other variables showed any multicollinear-
ity, therefore, they were entered into the multivariable
models automatically. For the protein and lipid-based
studies, additional variables were excluded on the basis of
clinical utility and the smallest F-statistics to reduce the
models to a number of parameters appropriate for the
reduced sample sizes.
Multivariable mixed-effects models
Model 1a (all variables measured across all studies plus
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peak BPP (P = 0.082), as well as bloating (P < 0.05) as
predictors of energy intake (Table 4); increases in antral
amplitude or peak BPP by 1 mmHg, or in bloating by
1 mmmin, while controlling for all the other variables,
were associated with an increase of 2.4 kJ, or decreases of
~37 kJ or ~0.2 kJ in energy intake, respectively. Model 1b
(all variables measured across all studies plus GLP-1)
identified a trend for peak CCK concentration
(P = 0.074), premeal GLP-1 concentration (P < 0.01),
and GLP-1 AUC (P < 0.01), and a trend for hunger
(P = 0.09) as determinants of energy intake. Increases in
CCK or GLP-1 by 1 pmol/L, in GLP-1 AUC by
1 pmolmin/L or in hunger AUC by 1 mmmin were
associated with reductions of ~66, ~27, and ~0.6 kJ, or an
increase of ~0.3 kJ, in energy intake, respectively.
Model 2a (lipid-based studies including PYY) identified
trends for number of premeal IPPWs (P = 0.057), peak
BPP (P = 0.067), and duodenal amplitude (P = 0.072), as
well as bloating (P < 0.001), as predictors of energy
intake, so that increases by n = 1, 1 mmHg, or
1 mmmin were associated with decreases of 15 kJ or
32 kJ, an increase of 5.4 kJ, or a decrease of ~0.2 kJ, in
energy intake, respectively (Table 4). In model 2b (lipid-
based studies including GLP-1), increases in peak BPP
and plasma CCK peak concentration were associated with
trends for an increase (P = 0.055), or a decrease
(P = 0.066), in energy intake, respectively; an increase in
peak BPP by 1 mmHg was associated with an increase in
energy intake of ~69 kJ, whereas an increase in plasma
CCK peak concentration by 1 pmol/L reduced energy
intake by ~80 kJ. The time-to-peak concentration of
plasma GLP-1 was also associated with energy intake
(P < 0.05); an increase by 1 min reduced energy intake
by ~11 kJ. Finally, there were trends for hunger
(P = 0.061) and nausea (P = 0.094) to be associated with
energy intake; increases in the hunger or nausea AUC by
1 mmmin were associated with an increase, or decrease,
in energy intake of 0.4 kJ, or 0.2 kJ, respectively.
Model 3 (all variables measured in the protein-based
studies) only identified peak BPP as an independent
determinant of energy intake (P < 0.05; Table 4); thus, an
increase by 1 mmHg was associated with a decrease in
energy intake of ~48 kJ.
Discussion
This study has evaluated, using a pooled-data analysis,
the GI motor and hormone determinants of acute energy
intake in response to intraduodenal administration of
nutrients, particularly protein and lipid. The major find-
ings are that the models, based either on all studies or the
lipid studies, identified a range of GI factors, including
amplitude of antral pressure waves, premeal GLP-1 and
time-to-peak GLP-1 concentrations, GLP-1 AUC and
bloating scores, and trends for BPP, amplitude of duode-
nal pressure waves, peak CCK concentrations, and hunger
and nausea scores, as independent determinants of energy
intake. In contrast, in the model that included the protein
studies only BPP was identified as an independent deter-
minant of energy intake. Moreover, the effects of variables
identified as independent determinants were small. That
said, it is important to recognize that the reported effects
relate to a change of 1 unit for each variable, for example,
an increase in plasma CCK by 1 pmol/L was associated
with a reduction in energy intake of ~66–80 kJ across
models, and lipid-stimulated plasma CCK may increase
by 3–5 pmol/L. Taken together, our observations indicate
that (i) the contributions of GI factors to energy intake
regulation are nutrient specific and (ii) while GI mecha-
nisms are important in the regulation of acute energy
intake (Cummings and Overduin 2007; Steinert et al.
2013), this effect most likely reflects the outcome of rela-
tively small, cumulative contributions from a range of
interrelated factors. A clear implication is that ‘GI’ strate-
gies for the management of obesity are unlikely to prove
effective if only one mechanism is targeted.
The studies included in this analysis utilized intraduo-
denal nutrient infusions, which allow the delivery of
nutrients into the proximal small intestine (the major
location of nutrient sensors, from which signals to initiate
feedback control of upper GI motility, slowing of gastric
emptying, and gut hormone release, are initiated) to be
standardized. The rationale for this approach is that it
excludes the confounding effects of the substantial
interindividual variation in gastric emptying and ‘by-
passes’ gastric distension which modulates energy intake.
In addition, the delivery of nutrients prior to a meal
“mimics” the preload concept, which aims to administer
nutrients that stimulate specific GI functions to influence
outcomes (e.g., energy intake or blood glucose) in
response to that meal (Gentilcore et al. 2006). We infused
long-chain triglyceride emulsions, whey protein, or their
digestive products, fatty acids, and amino acids, as these
have consistently been shown, in studies from our labora-
tory and those of others, to suppress subsequent energy
intake in humans when given acutely (Matzinger et al.
2000; Feltrin et al. 2004; Ryan et al. 2013).
Our main hypothesis was that with protein, unlike
lipid, GI factors were not the major driving force in
determining subsequent acute energy intake. Indeed, our
analysis identified a range of factors as contributors to
energy intake regulation in response to intraduodenal
lipid, whereas only a single factor, BPP, was identified for
protein, suggesting that other factors are more important
in the case of protein. Although these could not be deter-
mined in this study, important roles for, for example,
2016 | Vol. 4 | Iss. 17 | e12943
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diet-induced thermogenesis (Westerterp-Plantenga et al.
1999), intestinal gluconeogenesis (Mithieux 2009), and
direct effects of elevated plasma amino acid concentra-
tions within the brain (Tome 2004), have been identified
by others.
The increased recognition of the fundamental role for
the upper GI tract in regulating energy intake, but also
blood glucose, has prompted extensive research into
potential therapeutic agents that target these mechanisms.
Among the gut peptides, CCK, PYY, and GLP-1 have
received much interest, due to their satiating effects when
infused intravenously in healthy or obese humans, how-
ever, as has been shown in the case of PYY(3-36), the
satiating effects could only be achieved at doses that ele-
vated plasma PYY concentrations to supraphysiological
levels and also induced nausea (Degen et al. 2005). Inves-
tigations of the role of endogenous gut hormones have
been more limited, due to the relative lack of specific
receptor antagonists for use in humans. Studies using the
CCK-A receptor antagonist, loxiglumide, have shown that
blockade of CCK-A receptors has only a modest (Beglin-
ger et al. 2001), or no (Lieverse et al. 1995), effect to
increase energy intake, suggesting that while endogenous
CCK may play a role, its individual contribution is small.
GLP-1 agonists that stimulate insulin in a glucose-depen-
dent manner, but also slow gastric emptying, and, thus,
small intestinal glucose delivery and absorption, are now
widely used in the management of type 2 diabetes (Nauck
et al. 1997). Their use is also associated with a modest
reduction in body weight in obese patients with and with-
out type 2 diabetes, and the GLP-1 agonist, liraglutide, in
a dose of 3.0 mg, has recently been approved for manage-
ment of obesity in humans. However, these drugs are
expensive and associated with adverse effects, particularly
nausea and diarrhea (Horowitz et al. 2008), and their
longer-term safety remains uncertain. Their limited effect
to decrease body weight may reflect the targeting of only
one mechanism.
The notion that there is not a “dominant” GI factor,
but that numerous factors interact, to suppress energy
intake, is not surprising, considering that under physio-
logical conditions a range of hormones are released, and
other functions, including motility, are stimulated. For
example, we have shown that the potent suppressive
effects of specific nutrients, when administered intraduo-
denally, particularly the fatty acid, lauric acid, and also
the amino acid, L-tryptophan, on energy intake are associ-
ated with marked effects on the release of a number of
gut hormones and modulation of upper gut motility (Fel-
trin et al. 2004; Steinert et al. 2014). Further evidence for
the role of interrelated GI functions in the regulation of
energy intake comes from our previous pooled data anal-
ysis (Seimon et al. 2010), in which the magnitude of
stimulation of both pyloric pressures and plasma CCK
was identified as major independent determinants of sub-
sequent energy intake. In contrast to this previous analy-
sis, we were, however, unable to identify any specific
parameter as a major determinant of subsequent energy
intake. Instead, our data suggest that a number of factors
make small contributions to determine energy intake.
There was also an inconsistency; in model 2b (lipid-based
studies that measured GLP-1), an increase in peak BPP
by 1 mmHg was associated with a small increase, rather
than a decrease, in energy intake, which is difficult to rec-
oncile with our other findings. However, the statistical
analysis used considers each factor while keeping all other
variables constant, occasionally resulting in nonintuitive
outcomes.
Our observations are clinically relevant, given that they
provide evidence as to why any treatments that only tar-
get one pathway, for example, administration of a partic-
ular gut hormone, or its analog, are not, in the absence
of aversive effects, very effective in reducing energy intake
and, in the longer-term, body weight. A number of stud-
ies have investigated combination approaches (Gutzwiller
et al. 2004; Neary et al. 2005; Steinert et al. 2010) and
found that oral or intravenous administration of combi-
nations of gut hormones suppressed hunger or energy
intake more than individual gut hormones (reviewed in
(Steinert et al. 2016)). For example, in a recent study,
combined intravenous infusion of GLP-1 and PYY(3-36)
reduced energy intake compared with placebo more than
the sum of infusion of either hormone alone (Schmidt
et al. 2014). A similar approach has been used for combi-
nations of centrally acting drugs, for example, phenter-
mine and topiramate, although their side-effects are
considerable (Bray et al. 2016).
Our study has a number of limitations, which should
be taken into account in interpreting our data. Some gut
hormones that may modulate eating were either not mea-
sured (e.g., glucagon (Geary et al. 1992), pancreatic
polypeptide (Jesudason et al. 2007)), or measured only in
a small number of studies (e.g., ghrelin, insulin), and it
remains uncertain how their inclusion in the analyses
may have affected outcomes. These and other GI, or
extra-GI, mechanisms, not taken into account in our
studies, including plasma amino acid concentrations, war-
rant further investigation in prospective studies. As in our
previous study (Seimon et al. 2010), PYY was not identi-
fied as an independent determinant of energy intake, but
PYY was only assessed in a subset of studies, hence, the
analyses may have not been sufficiently powered. That
said, GLP-1 data were also available only in some studies,
yet, GLP-1 concentrations were identified as an indepen-
dent determinant of subsequent energy intake. The stud-
ies were performed in healthy, young men, hence, we
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cannot be certain that the findings can be extended to
women, overweight, obese, or elderly individuals,
although this is intuitively unlikely. As gastric distension
is involved in the acute regulation of energy intake, and
enhances the effect of intraduodenal nutrients on GI per-
ceptions (Feinle et al. 1997), the magnitude of effects
identified in our analyses may be greater in the presence
of gastric distension. Some selection of parameters to be
included into the models was required. Therefore, it is
possible that significant effects may have been confounded
with other parameters of the same outcome (e.g., for peak
vs. AUC vs. mean data of a variable). A statistical com-
parison of the lipid and protein cohorts to formally test
for a difference in the independent determinants was not
possible due to the available sample size. The comparison
of results between these two subgroups is therefore quali-
tative only. Finally, principle components analysis, as has
been used recently in a study to evaluate gastrointestinal
and psychological traits associated with obesity (Acosta
et al. 2015), was not deemed an appropriate analysis
method in the case of our data, as our data were collected
over multiple visits in each subject and there was cluster-
ing of subjects within separate studies.
In conclusion, our analysis indicates that a number of
GI factors, including GI pressures, plasma CCK, and
GLP-1 concentrations and some GI/appetite perception
variables, are determinants of energy intake at a subse-
quent meal in response to intraduodenal lipid, but to a
much lesser extent, protein. However, individual effects
were small, therefore, the overall effect on energy intake,
particularly by lipid, most likely reflects small, cumulative
contributions from a combination of these, interrelated,
factors. The findings have implications for the design of
effective approaches for the management of obesity that
target the GI tract, that is, these are unlikely to be effec-
tive if only one mechanism is targeted.
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